Cargando…

Efzofitimod: a novel anti-inflammatory agent for sarcoidosis

Efzofitimod is a first-in-class biologic immunomodulator based on a naturally occurring splice variant of histidyl-tRNA synthetase (HARS) that binds to neuropilin-2 (NRP2). Preclinical data found high expression of NRP2 in sarcoidosis granulomas. Treatment with efzofitimod reduced the granulomatous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baughman, Robert P., Niranjan, Vis, Walker, Gennyne, Burkart, Christoph, Paz, Suzanne, Chong, Yeeting E., Siefker, David, Sun, Eileen, Nangle, Leslie, Förster, Sarah, Muders, Michael H., Farver, Carol F., Lower, Elyse E., Shukla, Sanjay, Culver, Daniel A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099656/ https://www.ncbi.nlm.nih.gov/pubmed/36975051 http://dx.doi.org/10.36141/svdld.v40i1.14396

Ejemplares similares

Efzofitimod for the Treatment of Pulmonary Sarcoidosis
por: Culver, Daniel A., et al.
Publicado: (2023)

Exposure-response analyses of efzofitimod in patients with pulmonary sarcoidosis
por: Walker, Gennyne, et al.
Publicado: (2023)

Goldilocks, vitamin D and sarcoidosis
por: Baughman, Robert P, et al.
Publicado: (2014)

COVID-19 infections in sarcoidosis: a prospective single center study of 886 sarcoidosis patients
por: Baughman, Robert P., et al.
Publicado: (2021)

Accuracy of Serial PET-CT Imaging in Systemic Sarcoidosis
por: Carbone, Roberto G., et al.
Publicado: (2014)

Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel
por: Zhou, Ying, et al.
Publicado: (2015)

World Association for Sarcoidosis and Other Granulomatous Disease (WASOG) Centers of Excellence
por: Baughman, Robert P, et al.
Publicado: (2021)

Dual Medical Therapy for Treatment of Arrhythmias in Cardiac Sarcoidosis
por: Sibilia, Robert, et al.
Publicado: (2022)

COVID-19 and Sarcoidosis, Readiness for Vaccination: Challenges and Opportunities
por: Manansala, Michael, et al.
Publicado: (2021)

Roflumilast (Daliresp®) to reduce acute pulmonary events in fibrotic sarcoidosis: a multi-center, double blind, placebo controlled, randomized clinical trial
por: Baughman, Robert P, et al.
Publicado: (2021)

Clinical characteristics of sarcoidosis patients in the United States versus China
por: Zhou, Ying, et al.
Publicado: (2017)

Repository corticotropin for Chronic Pulmonary Sarcoidosis
por: Baughman, Robert P., et al.
Publicado: (2017)

SACE and IL-2R as serum biomarkers for evaluation of multi-organ involvement and prognosis of sarcoidosis
por: Zhou, Ying, et al.
Publicado: (2023)

Methotrexate in sarcoidosis: hematologic and hepatic toxicity encountered in a large cohort over a six year period
por: Baughman, Robert P., et al.
Publicado: (2020)

WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension
por: Savale, Laurent, et al.
Publicado: (2022)

Rituximab for refractory granulomatous eye disease
por: Lower, Elyse E, et al.
Publicado: (2012)

Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study
por: Rahaghi, Franck F., et al.
Publicado: (2020)

Discordance of the estrogen receptor and HER-2/neu in breast cancer from primary lesion to first and second metastatic site
por: Lower, Elyse E, et al.
Publicado: (2017)

Initial behaviors and attitudes towards the COVID-19 vaccine in sarcoidosis patients: Results of a self-reporting questionnaire
por: Vagts, Christen, et al.
Publicado: (2023)

Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire
por: Baughman, Robert P., et al.
Publicado: (2020)

Echocardiographic estimate of pulmonary artery pressure in sarcoidosis patients - real world data from a multi-national study
por: Huitema, Marloes P, et al.
Publicado: (2021)

When the Game Changes: Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 Pandemic
por: Sweiss, Nadera J., et al.
Publicado: (2020)

Pulmonary hypertension associated with sarcoidosis
por: Baughman, Robert P
Publicado: (2007)

Identifying a core outcome set for pulmonary sarcoidosis research – the Foundation for Sarcoidosis Research – Sarcoidosis Clinical OUtcomes Taskforce (SCOUT)
por: Harman, Nicola L., et al.
Publicado: (2022)

Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis
por: Rahaghi, Franck F., et al.
Publicado: (2020)

Editorial: Diagnosis and treatment of sarcoidosis
por: Zhou, Ying, et al.
Publicado: (2023)

Activity tracking devices in sarcoidosis
por: Klein, Rebecca A., et al.
Publicado: (2023)

Pulmonary Hypertension Associated Genetic Variants in Sarcoidosis Associated Pulmonary Hypertension
por: Groen, Karlijn, et al.
Publicado: (2022)

Chest high-resolution computed tomography can make higher accurate stages for thoracic sarcoidosis than X-ray
por: Zhang, Yuan, et al.
Publicado: (2022)

Pulmonary fibrosis in sarcoidosis
por: Asif, Huda, et al.
Publicado: (2023)

Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes
por: Saketkoo, Lesley Ann, et al.
Publicado: (2021)

Scout – sarcoidosis outcomes taskforce. A systematic review of outcomes to inform the development of a core outcome set for pulmonary sarcoidosis
por: Harman, Nicola L, et al.
Publicado: (2021)

Adalimumab in the treatment of cardiac sarcoidosis: Single center case series and narrative literature review
por: Sweis, Jaleel Jerry G., et al.
Publicado: (2022)

Comprehensive Care for Patients with Sarcoidosis
por: Moor, Catharina C., et al.
Publicado: (2020)

Clinical phenotyping: role in treatment decisions in sarcoidosis
por: Baughman, Robert P., et al.
Publicado: (2020)

Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review
por: Mirsaeidi, Mehdi, et al.
Publicado: (2022)

Isolation of monoclonal antibodies from anti-synthetase syndrome patients and affinity maturation by recombination of independent somatic variants
por: Burman, Luke, et al.
Publicado: (2020)

Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis
por: Drake, Wonder P., et al.
Publicado: (2021)

Diagnosis of pulmonary sarcoidosis in tuberculosis endemic area—a narrative review
por: Sodsri, Tulaton, et al.
Publicado: (2023)

Sarcoidosis: patient treatment priorities
por: Baughman, Robert P., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_raifgarc2ivcdqcsdshafih60a